David Einhorn's Best Week Ever
Tweet
Share
E-mail
Up)
David Einhorn is having his best week in, well, maybe ever. This week the hedge fund titan was making money hand over fist long and short, putting in company conference questions and dismantling the Fed.
Here is how Mr. Einhorn's week went down:
Monday: Einhorn wakes up bright and early.... today starts the week of all weeks.
Tuesday: Einhorn asks questions on Herbalife's (NYSE: HLF) conference call questioning the company's business model. While Einhorn didn’t disclose he is short the stock, it is pretty clear from the line of questioning that he is. Shares collapse more than 20 percent on the session and continue lower throughout most of the week. Currently the stock sits down more than 30 percent from the time of the Einhorn questioning.
Wednesday: After hours, long-time Einhorn short Green Mountain Coffee (Nasdaq: GMCR) reported results and things were ugly. The company missed second-quarter sales estimates and guided to lower profits ahead. Shares were slashed nearly 50 percent Thursday on the news. Shares are down about 70 percent since he first went short.
Thursday: In addition to counting his winnings in the Green Mountain short, Einhorn made headlines with his op-ed piece in the Huffington Post discussing Fed policy. He called it the "Jelly Donut Policy"... One Jelly Donut is yummy, two are an indulgent breakfast, three may induce a tummy ache, six is an eating disorder, and twelve is a fraternity pledge hazing...
Friday: Einhorn woke up to find his long-time investment in Einstein Noah (Nasdaq: BAGL) tapping new 52-week highs on strong first-quarter numbers and a decision to explore strategic alternatives. With shares up 14 percent, Einhorn's 64 percent stake is up a cool $22 million this morning.
We're sure Mr. Einhorn treated the staff at Greenlight Capital today with a bag of bagels, some jelly doughnuts, a single-serve coffee and vitamins.
Here is how Mr. Einhorn's week went down:
Monday: Einhorn wakes up bright and early.... today starts the week of all weeks.
Tuesday: Einhorn asks questions on Herbalife's (NYSE: HLF) conference call questioning the company's business model. While Einhorn didn’t disclose he is short the stock, it is pretty clear from the line of questioning that he is. Shares collapse more than 20 percent on the session and continue lower throughout most of the week. Currently the stock sits down more than 30 percent from the time of the Einhorn questioning.
Wednesday: After hours, long-time Einhorn short Green Mountain Coffee (Nasdaq: GMCR) reported results and things were ugly. The company missed second-quarter sales estimates and guided to lower profits ahead. Shares were slashed nearly 50 percent Thursday on the news. Shares are down about 70 percent since he first went short.
Thursday: In addition to counting his winnings in the Green Mountain short, Einhorn made headlines with his op-ed piece in the Huffington Post discussing Fed policy. He called it the "Jelly Donut Policy"... One Jelly Donut is yummy, two are an indulgent breakfast, three may induce a tummy ache, six is an eating disorder, and twelve is a fraternity pledge hazing...
Friday: Einhorn woke up to find his long-time investment in Einstein Noah (Nasdaq: BAGL) tapping new 52-week highs on strong first-quarter numbers and a decision to explore strategic alternatives. With shares up 14 percent, Einhorn's 64 percent stake is up a cool $22 million this morning.
We're sure Mr. Einhorn treated the staff at Greenlight Capital today with a bag of bagels, some jelly doughnuts, a single-serve coffee and vitamins.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Veralto Corporation (VLTO) Tops Q1 EPS by 6c, Offers Guidance
- West Fraser Timber Co. Ltd. (WFG) Tops Q1 EPS by 17c
Create E-mail Alert Related Categories
Hedge Funds, Insiders' Blog, Trader TalkRelated Entities
Greenlight Capital, David Einhorn, Hedge Funds, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
